
Hims & Hers faces tough challenge to meet 2026 revenue amid rising churn in oral Wegovy subscriptions.
Hims & Hers Health must add about 225,000 new oral Wegovy subscribers quarterly in 2026 to meet revenue targets, a high bar amid rising churn risks due to a subscription price increase from $39 to $149 after the first month. Bank of America warns thi...

